Showing 15 posts of 771 posts found.


Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018
Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …


Investigation of kickbacks in Greece sputters to halt

May 21, 2018
Sales and Marketing Greece, Novartis, biotech, drugs, pharma, pharmaceutical

Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …


Ebola threat intensifies in DR Congo

May 18, 2018
Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …


Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018
Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …

Study finds Herceptin use can be halved

May 17, 2018
Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical

A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …

Ipsen receives European first-line approval for Cabometyx

May 17, 2018
Sales and Marketing Cabometyx, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced …


UK MPs call for Brexit priority over pharma industry

May 17, 2018
Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical

A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …


Roche gets NICE approval for advanced bladder cancer

May 17, 2018
Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …


How to treat colds? Target the person, not the virus

May 15, 2018
Research and Development biotech, common cold, drugs, pharma, pharmaceutical

Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …


FDA issues warning letter over potential for poisoning at India plant

May 15, 2018
Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical

The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …


Smell test targets asymptomatic malaria carriers

May 15, 2018
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …


Emergex secures funds in race to develop universal flu vaccine

May 15, 2018
Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical

UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …

Takeda financials show why the Shire deal was needed

May 14, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …


Pharma unfazed by Trump price-reduction proposals

May 14, 2018
Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …

Latest content